Mice engrafted with MV4-11 ctrl-GFP-SALL1 treated cells developed AML and died on an average of 5 weeks, significantly earlier than those engrafted with MV4-11 sh-SALL1 cells. Here, SALL1 is linked to acute myeloid leukemia.